SEC Form 4 · accession 0001209191-16-093925
BioAmber Inc. · BIOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean-Francois Huc
Officer — President and CEO · Director
Period of report
Jan 26, 2016
Accepted (ET)
Jan 28, 2016 · 1:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534287
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $5.00 | Jan 26, 2016 | A | 200,000 | A | — | Jan 26, 2026 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The exercise price represents a premium of $0.86 per share over grant date closing market price of BioAmber Inc. common stock on the New York Stock Exchange of $4.14 per share.
- F2These options will vest as follows: 25% will vest on 01/26/2017; the remaining 75% will vest on a monthly basis over the three (3) following years.